Statistics of SECUKINUMAB, A HUMAN ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, IMPROVES ACTIVE PSORIATIC ARTHRITIS AND INHIBITS RADIOGRAPHIC PROGRESSION: EFFICACY AND SAFETY DATA FROM A PHASE 3 RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
